IGF1 potentiates BMP9-induced osteogenic differentiation in mesenchymal stem cells through the enhancement of BMP/Smad signaling
2
조회
0
다운로드
1
인용
0
참고문헌
키워드
초록
Engineered bone tissue is thought to be the ideal alternative for bone grafts in the treatment of related bone diseases. BMP9 has been demonstrated as one of the most osteogenic factors, and enhancement of BMP9-induced osteogenesis will greatly accelerate the development of bone tissue engineering. Here, we investigated the effect of insulin-like growth factor 1 (IGF1) on BMP9-induced osteogenic differentiation, and unveiled a possible molecular mechanism underling this process. We found that IGF1 and BMP9 are both detectable in mesenchymal stem cells (MSCs). Exogenous expression of IGF1 potentiates BMP9-induced alkaline phosphatase (ALP), matrix mineralization, and ectopic bone formation. Similarly, IGF1 enhances BMP9-induced endochondral ossification. Mechanistically, we found that IGF1 increases BMP9-induced activation of BMP/Smad signaling in MSCs. Our findings demonstrate that IGF1 can enhance BMP9-induced osteogenic differentiation in MSCs, and that this effect may be mediated by the enhancement of the BMP/Smad signaling transduction triggered by BMP9.
Abstract
Engineered bone tissue is thought to be the ideal alternative for bone grafts in the treatment of related bone diseases. BMP9 has been demonstrated as one of the most osteogenic factors, and enhancement of BMP9-induced osteogenesis will greatly accelerate the development of bone tissue engineering. Here, we investigated the effect of insulin-like growth factor 1 (IGF1) on BMP9-induced osteogenic differentiation, and unveiled a possible molecular mechanism underling this process. We found that IGF1 and BMP9 are both detectable in mesenchymal stem cells (MSCs). Exogenous expression of IGF1 potentiates BMP9-induced alkaline phosphatase (ALP), matrix mineralization, and ectopic bone formation. Similarly, IGF1 enhances BMP9-induced endochondral ossification. Mechanistically, we found that IGF1 increases BMP9-induced activation of BMP/Smad signaling in MSCs. Our findings demonstrate that IGF1 can enhance BMP9-induced osteogenic differentiation in MSCs, and that this effect may be mediated by the enhancement of the BMP/Smad signaling transduction triggered by BMP9.
참고문헌 (36)
- Harada N, "Bone regeneration in a massive rat femur defect through endochondral ossification achieved with chondrogenically differentiated MSCs in a degradable scaffold", Biomaterials, 35, pp.7800~7810 (2014)
- Amini AR, "Bone tissue engineering: recent advances, challenges", Crit Rev Biomed Eng, 40, pp.363~408 (2012)
- Huang J, "The role of COX-2 in mediating the effect of PTEN on BMP9 induced osteogenic differentiation in mouse embryonic fibroblasts", Biomaterials, 35, pp.9649~9659 (2014)
- Kang Q, "Characterization of the distinct orthotopic bone-forming activity of 14 BMPs using recombinant adenovirus-mediated gene delivery", Gene Ther, 11, pp.1312~1320 (2004)
- Khosla S, "Building bone to reverse osteoporosis, repair fractures", J Clin Invest, 118, pp.421~428 (2008)
- Cooper GS, "Risk of cancer after lumbar fusion surgery with recombinant human bone morphogenic protein-2(rh-BMP-2)", Spine(Phila Pa 1976), 38, pp.1862~1868 (2013)
- Zhang H, "Canonical Wnt signaling acts synergistically on BMP9-induced osteo", odontoblastic differentiation of stem cells of dental apical papilla(SCAPs), 2014, pp.39C, 145~154
- Zhang W, "Retinoic acids potentiate BMP9-induced osteogenic differentiation of mesenchymal progenitor cells", PLoS One, 5, pp.e11917~ (2010)
- Wang JH, "BMP9, COX-2 form an important regulatory loop in BMP9-induced osteogenic differentiation of mesenchymal stem cells", Bone, 57, pp.311~321 (2013)
- Sullivan KA, "Insulin-like growth factors in the peripheral nervous system", Endocrinology, 149, pp.5963~5971 (2008)
- Patil AS, "Role of insulin-like growth factors(IGFs), their receptors, genetic regulation in the chondrogenesis, growth of the mandibular condylar cartilage", J Cell Physiol, 227, pp.1796~1804 (2012)
- Wang L, "Endothelial insulinlike growth factor-1 modulates proliferation, phenotype of smooth muscle cells induced by low shear stress", Ann Biomed Eng, 42, pp.776~786 (2014)
- Kim S, "Sequential delivery of BMP-2, IGF-1 using a chitosan gel with gelatin microspheres enhances early osteoblastic differentiation", Acta Biomater, 8, pp.1768~1777 (2012)
- Joung YH, "Hwanggeumchal sorghum extract enhances BMP7, GH signaling through the activation of Jak2", STAT5B in MC3T3E1 osteoblastic cells, 2013, pp.8, 891~896
- Perrini S, "The GH", IGF1 axis, signaling pathways in the muscle, bone: mechanisms underlying age-related skeletal muscle wasting, osteoporosis, 2010, pp.205, 201~210
- Sheng MH, "Disruption of the insulin-like growth factor-1gene in osteocytes impairs developmental bone growth in mice", Bone, 52, pp.133~144 (2013)
- Yoon DM, "Chondrocyte signaling, artificial matrices for articular cartilage engineering", Adv Exp Med Biol, 585, pp.67~86 (2006)
- Chen D, "Bone morphogenetic proteins", Growth Factors, 22, pp.233~241 (2004)
- Lamplot JD, "BMP9 signaling in stem cell differentiation, osteogenesis", Am J Stem Cells, 2, pp.1~21 (2013)
- Liu Y, "All-trans retinoic acid modulates bone morphogenic protein 9-induced osteogenesis, adipogenesis of preadipocytes through BMP", Smad, Wnt, Int J Biochem Cell Biol, pp.2014, 47[DOI]
- Chen L, "Insulin-like growth factor 2(IGF-2)potentiates BMP-9-induced osteogenic differentiation, bone formation", J Bone Miner Res, 25, pp.2447~2459 (2010)
- Huat TJ, "IGF-1 enhances cell proliferation, survival during early differentiation of mesenchymal stem cells to neural progenitor-like cells", BMC Neurosci, 15, pp.91~ (2014)
- Livingstone C, "IGF2, cancer", Endocr Relat Cancer, 20, pp.R321~R339 (2013)
- Brouwer-Visser J, "IGF2 signaling, regulation in cancer", Cytokine Growth Factor Rev, 26, pp.371~377 (2015)
- Svensson J, "Liver-derived IGF-I regulates kidney size, sodium reabsorption, , renal IGF-II expression", J Endocrinol, 193, pp.359~366 (2007)
- Sjogren K, "Effects of liver-derived insulin-like growth factor I on bone metabolism in mice", J Bone Miner Res, 17, pp.1977~1987 (2002)
- Tirapegui J, "Effect of insulin-like growth factor-1(IGF-1)on muscle, bone growth in experimental models", Int J Food Sci Nutr, 50, pp.231~236 (1999)
- Schlegel W, "Insulinlike growth factor I(IGF-1)Ec", Mechano Growth factor--a splice variant of IGF-1 within the growth plate, 2013, pp.8, e76133~
- Brown-Borg HM, "GH, IGF1: roles in energy metabolism of long-living GH mutant mice", J Gerontol A Biol Sci Med Sci, 67, pp.652~660 (2012)
- Junnila RK, "The GH", IGF-1 axis in ageing, longevity, 2013, pp.9, 366~376
- David J. Baylink, "Role of Osteocyte-derived Insulin-Like Growth Factor I in Developmental Growth, Modeling, Remodeling, and Regeneration of the Bone", 대한골대사학회지, 21(1), pp.41~54 (2014), 대한골대사학회
- Ferretti C, "Role of IGF1and IGF1", VEGF on human mesenchymal stromal cells in bone healing: two sources, two fates, 2014, pp.20, 2473~2482
- Retting KN, "BMP canonical Smad signaling through Smad1, Smad5 is required for endochondral bone formation", Development, 136, pp.1093~1104 (2009)
- David L, "Identification of BMP9, BMP10 as functional activators of the orphan activin receptor-like kinase 1(ALK1)in endothelial cells", Blood, 109, pp.1953~1961 (2007)
- Luo J, "A protocol for rapid generation of recombinant adenoviruses using the AdEasy system", Nat Protoc, 2, pp.236~1247 (2007)
- Zhao M, "E3 ubiquitin ligase Smurf1 mediates core-binding factor alpha1", Runx2 degradation, plays a specific role in osteoblast differentiation, 2003, pp.278, 27939~27944
